Latest News
New in vitro and in vivo studies demonstrate the presence of precursor cells with the characteristics of interneurons.
A novel tool has added some clarity to the role of granulins in dementia, and highlighted them as a potential treatment target.
The California Institute for Regenerative Medicine (CIRM) announces that it is investing $15.9 million in a therapy to tackle ALS.
Journal Articles
Preliminary findings suggest that some cell therapies may be relatively safe and effective, but larger double-blinded placebo-controlled studies are needed to establish the long-term risks and benefits.
This article discusses two potential neural networks, the serotonergic system and the OTergic system, that could prove to be particularly useful targets for endocrine therapy.
This systematic review provides a summary of the blood protein biomarkers that have been studied for the diagnosis of acute ischemic stroke.
Autoimmune
Multiple sclerosis research suggests a neuroprotective benefit following resistance training
Parkinson’s is partly an autoimmune disease, new study states
Autoantibodies in neurological disorders – a review from Judith Greer
Cerebrovascular disease
Blood protein biomarkers as diagnostic tool for ischemic stroke: a systematic review
CNS/PNS/SNS
Neurogenesis takes place in the amygdala of mice
Granulin research opens avenues for frontotemporal dementia treatment
Cognitive/neurodegenerative disorders
TBI, animal models and neuroimaging: David Brody at Frontiers in TBI
Granulin research opens avenues for frontotemporal dementia treatment
CTE pathology and controversy: Lee Goldstein at Frontiers in TBI
Demyelinating disease
Human herpes virus 6 may hamper the brain's ability to repair damaged cells
Development and pediatrics
Epilepsy and seizure
Technological advances in pediatric epilepsy surgery: implications for tuberous sclerosis complex
Epilepsy drug receives approval as monotherapy from European Medicines Agency
Genetics
NCTalks at AAIC 2017: Julie Williams on Alzheimer’s genetics
DNA methylation and transcription onset in the brain
Small-molecule BDNF mimetic may improve symptoms of Rett syndrome
Headache
EAN 2017: Monoclonal antibody could be an effective treatment for chronic migraine
EAN 2017: Cannabinoids suitable for migraine prophylaxis
Noninvasive brain stimulation: an interview with Eric Wasserman
Immune disorders and inflammation
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Parkinson’s is partly an autoimmune disease, new study states
Infection
NS1-based Zika vaccine demonstrates promise in mice
Zika virus to be investigated as novel glioblastoma treatment
Injury/trauma
'Should we retire the term concussion?': live debate from Frontiers in TBI
TBI, animal models and neuroimaging: David Brody at Frontiers in TBI
CTE pathology and controversy: Lee Goldstein at Frontiers in TBI
Movement disorders
CIRM: Phase III clinical trial targeting Lou Gehrig's disease gets US$15.9 million investment
Neuro-ophthalmology
Management of glaucoma as a neurodegenerative disease
Genetic analysis identifies loci associated with macular telangiectasia type 2
The best of 2016 on Neurology Central – a note from the Editor
Neurometabolic
Could the gut microbiome hold the key to neurodegenerative disorders?
The best of 2016 on Neurology Central – a note from the Editor
Energy drinks and alcohol may affect adolescent brains in similar way to cocaine
Neuromuscular
Novel discovery in motor neuron disease may pave the way for future treatments
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Neuropsychiatry
Honing in on hormone-sensitive neural targets for therapeutic intervention: mission impossible?
NCTalks at AAIC 2017: Megan Zuelsdorff on lifetime stress, racial disparities and cognitive health
Neurotransmitter receptor genotypes associated with mental and behavioral disorders
Oncology/tumor
Novel drug target identified for glioblastoma treatment
Role of cellular prion protein in neurofibromatosis 2 tumor development uncovered
Alzheimer’s disease patients may have a lower risk of developing lung cancer
Pain
EAN 2017: Monoclonal antibody could be an effective treatment for chronic migraine
EAN 2017: Cannabinoids suitable for migraine prophylaxis
Recent advances in spinal cord stimulation for pain treatment
Sleep
Poor sleep quality associated with presence of Alzheimer’s disease biomarkers
Light, sleep and circadian rhythms in older adults with Alzheimer's disease and related dementias
#NCintroduces… Mammalian chronobiology and circadian rhythms